Opposite modulation of peripheral inflammation and neuroinflammation by adenosine A2A receptors

Interaction Between Neurons and Glia in Aging and Disease

Volumn , Issue , 2007, Pages 53-79

  Cunha, Rodrigo A ^a   Chen, Jiang Fan ^b   Sitkovsky, Michail V ^c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 47349109066     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-70830-0_3     Document Type: Chapter

References (225)

1. Aisen, P.S., Schafer, K.A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K.L., Farlow, M.R., Jin, S., Thomas, R.G. and Thal, L.J., Alzheimer's Disease Cooperative Study, 2003, Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 289: 2819.
2. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G.M., Cooper, N.R., Eikelenboom, P., Emmerling, M., Fiebich, B.L., Finch, C.E., Frautschy, S., Griffin, W.S., Hampel, H., Hull, M., Landreth, G., Lue, L., Mrak, R., Mackenzie, I.R., McGeer, P.L., et al., 2000, Inflammation and Alzheimer's disease. Neurobiol. Aging 21: 383.
3. Aloisi, F., Ambrosini, E., Columba-Cabezas, S., Magliozzi, R. and Serafini, B., 2001, Intracerebral regulation of immune responses. Ann. Med. 33: 510.
4. Andersen, J.K., 2004, Oxidative stress in neurodegeneration: cause or consequence? Nat. Med. 10: S18.
5. Angelov, D.N., Waibel, S., Guntinas-Lichius, O., Lenzen, M., Neiss, W.F., Tomov, T.L., Yoles, E., Kipnis, J., Schori, H., Reuter, A., Ludolph, A., and Schwartz, M., 2003, Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 100: 4790.
6. Angulo, E., Casadó, V., Mallol, J., Canela, E.I., Vinals, F., Ferrer, I., Lluis, C. and Franco, R., 2003, A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation. Brain Pathol. 13: 440.
7. Apasov, S., Chen, J.F., Smith, P. and Sitkovsky, M., 2000, A2A receptor dependent and A2A receptor independent effects of extracellular adenosine on murine thymocytes in conditions of adenosine deaminase deficiency. Blood 95: 3859.
8. Baldwin, S.A., Beal, P.R., Yao, S.Y., King, A.E., Cass, C.E. and Young, J.D., 2004, The equilibrative nucleoside transporter family, SLC29. Pflugers Arch. 447: 735.
9. Barouch, R. and Schwartz, M., 2002, Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: implications for protective autoimmunity. FASEB J. 16: 1304.
10. Batchelor, P.E., Liberatore, G.T., Wong, J.Y., Porritt, M.J., Frerichs, F., Donnan, G.A. and Howells, D.W., 1999, Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brainderived neurotrophic factor and glial cell line-derived neurotrophic factor. J. Neurosci. 19: 1708.
11. Beal, M.F., 2003, Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann. N.Y. Acad. Sci. 991: 120.
12. Bechmann, I., 2003, Failed central nervous system regeneration: a downside of immune privilege? Neuromolecular Med. 7: 217.
13. Benner, E.J., Mosley, R.L., Destache, C.J., Lewis, T.B., Jackson-Lewis, V., Gorantla, S., Nemachek, C., Green, S.R., Przedborski, S. and Gendelman, H.E., 2004, Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease. Proc. Natl Acad. Sci. USA 101: 9435.
14. Block, M.L. and Hong, J.S., 2005, Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog. Neurobiol. 76: 77.
15. Boireau, A., Bordier, F., Dubedat, P., Peny, C. and Imperato, A., 1997, Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice. Neurosci. Lett. 234: 123.
16. Bouma, M.G., Jeunhomme, T.M., Boyle, D.L., Dentener, M.A., Voitenok, N.N., van den Wildenberg, F.A. and Buurman, W.A., 1997, Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors. J. Immunol. 158: 5400.
17. Brambilla, R., Cottini, L., Fumagalli, M., Ceruti, S. and Abbracchio, M.P., 2003, Blockade of A2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes. Glia 43: 190.
18. Brodie, C., Blumberg, P.M. and Jacobson, K.A., 1998, Activation of the A2A adenosine receptor inhibits nitric oxide production in glial cells. FEBS Lett. 429: 139.
19. Bshesh, K., Zhao, B., Spight, D., Biaggioni, I., Feokistov, I., Denenberg, A., Wong, H.R. and Shanley, T.P., 2002, The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells. J. Leukoc. Biol. 72: 1027.
20. Cardona, A.E., Pioro, E.P., Sasse, M.E., Kostenko, V., Cardona, S.M., Dijkstra, I.M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., Lee, J.C., Cook, D.N., Jung, S., Lira, S.A., Littman, D.R. and Ransohoff, R.M., 2006, Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9: 917.
21. Carson, M.J. and Sutcliffe, J.G., 1999, Balancing function vs. self defense: the CNS as an active regulator of immune responses. J. Neurosci. Res. 55: 1.
22. Cassada, D.C., Tribble, C.G., Laubach, V.E., Nguyen, B.N., Rieger, J.M., Linden, J., Kaza, A.K., Long, S.M., Kron, I.L. and Kern, J.A., 2001, An adenosine A2A agonist, ATL-146e, reduces paralysis and apoptosis during rabbit spinal cord reperfusion. J. Vasc. Surg. 34: 482.
23. Cassada, D.C., Tribble, C.G., Long, S.M., Laubach, V.E., Kaza, A.K., Linden, J., Nguyen, B.N., Rieger, J.M., Fiser, S.M., Kron, I.L. and Kern, J.A., 2002, Adenosine A2A analogue ATL-146e reduces systemic tumor necrosing factor-alpha and spinal cord capillary platelet-endothelial cell adhesion molecule-1 expression after spinal cord ischemia. J. Vasc. Surg. 35: 994.
24. Castren, E., 2004, Neurotrophins as mediators of drug effects on mood, addiction, and neuroprotection. Mol. Neurobiol. 29: 289.
25. Chen, J.F., Xu, K., Petzer, J.P., Staal, R., Xu, Y.H., Beilstein, M., Sonsalla, P.K., Castagnoli, K., Castagnoli, N. Jr. and Schwarzschild, M.A., 2001, Neuroprotection by caffeine and A2A adenosine receptor inactivation in a model of Parkinson's disease. J. Neurosci. 21: RC143.
26. Chen, H., Zhang, S.M., Hernan, M.A., Schwarzschild, M.A., Willett, W.C., Colditz, G.A., Speizer, F.E. and Ascherio, A., 2003, Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch. Neurol. 60: 1059.
27. Ciruela, F., Casadó, V., Rodrigues, R.J., Lujan, R., Burgueño, J., Canals, M., Borycz, J., Rebola, N., Goldberg, S.R., Mallol, J., Cortes, A., Canela, E.I., Lopez-Gimenez, J.F., Milligan, G., Lluis, C., Cunha, R.A., Ferré, S. and Franco, R., 2006, Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J. Neurosci. 26: 2080.
28. Coelho, J.E., de Mendonça, A. and Ribeiro, J.A., 2000, Presynaptic inhibitory receptors mediate the depression of synaptic transmission upon hypoxia in rat hippocampal slices. Brain Res. 869: 158.
29. Coelho, J.E., Rebola, N., Fragata, I., Ribeiro, J.A., de Mendonça, A. and Cunha, R.A., 2006, Hypoxia-induced desensitization and internalization of adenosine A1 receptors in the rat hippocampus. Neuroscience 138: 1195.
30. Cohen, S.B., Gill, S.S., Baer, G.S., Leo, B.M., Scheld, W.M. and Diduch, D.R., 2004, Reducing joint destruction due to septic arthrosis using an adenosine 2A receptor agonist. J. Orthop. Res. 22: 427.
31. Cunha, R.A., 2001, Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem. Int. 38: 107.
32. Cunha, R.A., 2005, Neuroprotection by adenosine in the brain: from A1 receptor activation to A2A receptor blockade. Purinergic Signal 1: 111.
33. Cunha, R.A., Correia-de-Sá, P., Sebastião, A.M. and Ribeiro, J.A., 1996a, Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides. Br. J. Pharmacol. 119: 253.
34. Cunha, R.A., Vizi, E.S., Ribeiro, J.A. and Sebastião, A.M., 1996b, Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices. J. Neurochem. 67: 2180.
35. Cunha, G.M.A., Canas, P.M., Oliveira, C.R. and Cunha, R.A., 2006, Increased density and synapto-protective effect of adenosine A2A receptors upon sub-chronic restraint stress. Neuroscience 141: 1775.
36. Davalos, D., Grutzendler, J., Yang, G., Kim, J.V., Zuo, Y., Jung, S., Littman, D.R., Dustin, M.L. and Gan, W.B., 2005, ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 8: 752.
37. Day, Y.J., Huang, L., McDuffie, M.J., Rosin, D.L., Ye, H., Chen, J.F., Schwarzschild, M.A., Fink, J.S., inden, J. and Okusa, M.D., 2003, Renal protection from ischemia mediated by A2A adenosine receptors on bone marrowderived cells. J. Clin. Invest. 112: 883.
38. Day, Y.J., Marshall, M.A., Huang, L., McDuffie, M.J., Okusa, M.D. and Linden, J., 2004, Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am. J. Physiol. 286: G285.
39. + T cells and INF-?. J. Immunol. 176: 3108.
40. de Mendonça, A. and Ribeiro, J.A., 1997, Adenosine and neuronal plasticity. Life Sci. 60: 245.
41. de Mendonça, A., Sebastião, A.M. and Ribeiro, J.A., 2000, Adenosine: does it have a neuroprotective role after all? Brain Res. Rev. 33: 258.
42. de Simone, R., Ajmone-Cat, M.A. and Minghetti, L., 2004, Atipical anti-inflammatory activation of microglia induced by apoptotic neurons: possible role of phosphatidylserine-phosphatidylserine receptor interaction. Mol. Neurobiol. 29: 197.
43. Dixon, A.K., Widdowson, L. and Richardson, P.J., 1997, Desensitisation of the adenosine A1 receptor by the A2A receptor in the rat striatum. J. Neurochem. 69: 315.
44. Dodart, J.C., Bales, K.R., Gannon, K.S., Greene, S.J., DeMattos, R.B., Mathis, C., DeLong, C.A., Wu, S., Wu, X., Holtzman, D.M. and Paul, S.M., 2002, Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. Nat. Neurosci. 5: 452.
45. Dong, Y. and Benveniste, E.N., 2001, Immune function of astrocytes. Glia 36: 180.
46. Duarte, J.M., Oliveira, C.R., Ambrósio, A.F. and Cunha, R.A., 2006, Modification of adenosine A1 and A2A receptor density in the hippocampus of streptozotocin-induced diabetic rats. Neurochem. Int. 48: 144.
47. Dunwiddie, T.V., 1999, Adenosine and suppression of seizures. Adv. Neurol. 79: 1001.
48. Dunwiddie, T.V. and Masino, S.A., 2001 The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24: 31.
49. Ekdahl, C.T., Claasen, J.H., Bonde, S., Kokaia, Z. and Lindvall, O., 2003, Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl Acad. Sci. USA 100: 13632.
50. Elkabes, S., DiCicco-Bloom, E.M. and Black, I.B., 1996, Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J. Neurosci. 16: 2508.
51. Elward, K. and Gasque, P., 2003, "Eat me" and "don't eat me" signals govern the innate immune response and tissue repair in the CNS: emphasis on the critical role of the complement system. Mol. Immunol. 40: 85.
52. Farber, K. and Kettenmann, H., 2005, Physiology of microglial cells. Brain Res. Rev. 48: 133.
53. Faulkner, J.R., Herrmann, J.E., Woo, M.J., Tansey, K.E., Doan, N.B. and Sofroniew, M.V., 2004, Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 24: 2143.
54. Fedele, D.E., Li, T., Lan, J.Q., Fredholm, B.B. and Boison, D., 2006 Adenosine A1 receptors are crucial in keeping an epileptic focus localized. Exp. Neurol. 200: 184.
55. Fellin, T. and Carmignoto, G., 2004, Neurone-to-astrocyte signaling in the brain represents a distinct multifunctional unit. J. Physiol. 559: 3.
56. Ferré, S., Borycz, J., Goldberg, S.R., Hope, B.T., Morales, M., Lluis, C., Franco, R., Ciruela, F. and Cunha, R.A., 2005, Role of adenosine in the control of homosynaptic plasticity in striatal excitatory synapses. J. Integr. Neurosci. 4: 445.
57. Fiebich, B.L., Biber, K., Lieb, K., van Calker, D., Berger, M., Bauer, J. and Gebicke-Haerter, P.J., 1996, Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors. Glia 18: 152.
58. Flugel, A., Matsumuro, K., Neumann, H., Klinkert, W.E., Birnbacher, R., Lassmann, H., Otten, U. and Wekerle, H., 2001, Anti-inflammatory activity of nerve growth factor in experimental autoimmune encephalomyelitis: inhibition of monocyte transendothelial migration. Eur. J. Immunol. 31: 11.
59. Fredholm, B.B., 1997, Adenosine and neuroprotection. Int. Rev. Neurobiol. 40: 259.
60. Fredholm, B.B., IJzerman, A.P., Jacobson, K.A., Klotz, K.N. and Linden, J., 2001, International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53: 527.
61. Fredholm, B.B., Cunha, R.A. and Svenningsson, P., 2003, Pharmacology of adenosine A2A receptors and therapeutic applications. Curr. Top. Med. Chem. 3: 413.
62. Fredholm, B.B., Chen, J.F., Cunha, R.A., Svenningsson, P. and Vaugeois, J.M., 2005, Adenosine and brain function. Int. Rev. Neurobiol. 63: 191.
63. Gandy, S. and Heppner, F.L., 2005, Alzheimer's amyloid immunotherapy: quo vadis? Lancet Neurol. 4: 452.
64. Gao, H.M., Liu, B., Zhang, W. and Hong, J.S., 2003, Novel anti-inflammatory therapy for Parkinson's disease. Trends Pharmacol. Sci. 24: 395.
65. Gasque, P., Dean, Y.D., McGreal, E.P., VanBeek, J. and Morgan, B.P., 2000, Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology 49: 171.
66. Gebicke-Haerter, P.J., 2001, Microglia in neurodegeneration: molecular aspects. Microsc. Res. Tech. 54: 47.
67. Gebicke-Haerter, P.J., Christoffel, F., Timmer, J., Northoff, H., Berger, M. and Van Calker, D., 1996, Both adenosine A1- and A2-receptors are required to stimulate microglial proliferation. Neurochem. Int. 29: 37.
68. Gerevich, Z., Wirkner, K. and Illes, P., 2002, Adenosine A2A receptors inhibit the N-methyl-D-aspartate component of excitatory synaptic currents in rat striatal neurons. Eur. J. Pharmacol. 451: 161.
69. Giovannoni, G. and Baker, D., 2003, Inflammatory disorders of the central nervous system. Curr. Opin. Neurol. 16: 347.
70. Giraudon, P., Vincent, P. and Vuaillat, C., 2005, T-cells in neuronal injury and repair: semaphorins and related T-cell signals. Neuromol. Med. 7: 207.
71. Greene, R.W. and Haas, H.L., 1991, The electrophysiology of adenosine in the mammalian central nervous system. Prog. Neurobiol. 36: 329.
72. Hammarberg, H., Lidman, O., Lundberg, C., Eltayeb, S.Y., Gielen, A.W., Muhallab, S., Svenningsson, A., Linda, H., van Der Meide, P.H., Cullheim, S., Olsson, T. and Piehl, F., 2000, Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J. Neurosci. 20: 5283.
73. Hanisch, U.K., 2002, Microglia as a source and target of cytokines. Glia 40: 140.
74. Harada, N., Okajima, K., Murakami, K., Usune, S., Sato, C., Ohshima, K. and Katsuragi, T., 2000, Adenosine and selective A2A receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation. J. Pharmacol. Exp. Ther. 294: 1034.
75. Harrison, J.K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R.K., Streit, W.J., Salafranca, M.N., Adhikari, S., Thompson, D.A., Botti, P., Bacon, K.B. and Feng, L., 1998, Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl Acad. Sci. USA 95: 10896.
76. Hartmann, A., Hunot, S. and Hirsch, E.C., 2003, Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter. Exp. Neurol. 184: 561.
77. Hasko, G. and Cronstein, B.N., 2004. Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 25: 33.
78. Hasko, G., Kuhel, D.G., Chen, J.F., Schwarzschild, M.A., Deitch, E.A., Mabley, J.G., Marton, A. and Szabo, C., 2000, Adenosine inhibits IL-12 and TNF-á production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J. 14: 2065.
79. Hasko, G., Pacher, P., Vizi, E.S. and Illes, P., 2005, Adenosine receptor signaling in the brain immune system. Trends Pharmacol. Sci. 26: 511.
80. Hauwel, M., Furon, E., Canova, C., Griffiths, M., Neal, J. and Gasque, P., 2005, Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, "protective" glial stem cells and stromal ependymal cells. Brain Res. Rev. 48: 220.
81. Heese, K., Fiebich, B.L., Bauer, J. and Otten, U., 1997, Nerve growth factor (NGF) expression in rat microglia is induced by adenosine A2a-receptors. Neurosci. Lett. 231: 83.
82. Heese, K., Hock, C. and Otten, U., 1998, Inflammatory signals induce neurotrophin expression in human microglial cells. J. Neurochem. 70: 699.
83. Herrera, A.J., Tomas-Camardiel, M., Venero, J.L., Cano, J. and Machado, A., 2005, Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons. J. Neural Transm. 112: 111.
84. Herx, L.M., Rivest, S. and Yong, V.W., 2000, Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1? is required for the production of ciliary neurotrophic factor. J. Immunol. 165: 2232.
85. Hickey, W.F., Hsu, B.L. and Kimura, H., 1991, T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28: 254.
86. Hindley, S., Herman, M.A. and Rathbone, M.P., 1994, Stimulation of reactive astrogliosis in vivo by extracellular adenosine diphosphate or an adenosine A2 receptor agonist. J. Neurosci. Res. 38: 399.
87. Hirsch, E.C., Breidert, T., Rousselet, E., Hunot, S., Hartmann, A. and Michel, P.P., 2003, The role of glial reaction and inflammation in Parkinson's disease. Ann. N.Y. Acad. Sci. 991: 214.
88. Hirschberg, D.L., Moalem, G., He, J., Mor, F., Cohen, I.R. and Schwartz, M., 1998, Accumulation of passively transferred primed T cells independently of their antigen specificity following central nervous system trauma. J. Neuroimmunol. 89: 88.
89. Huang, S., Apasov, S., Koshiba, M. and Sitkovsky, M., 1997, Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 90: 1600.
90. Inoue, K., 2006, The function of microglia through purinergic receptors: Neuropathic pain and cytokine release. Pharmacol. Ther. 109: 210.
91. int' Veld, B.A., Ruitenberg, A., Hofman, A., Launer, L.J., van Duijn, C.M., Stijnen, T., Breteler, M.M. and Stricker, B.H., 2001, Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N. Engl. J. Med. 345: 1515.
92. Irani, D.N., Lin, K.I. and Griffin, D.E., 1997, Regulation of brain-derived T cells during acute central nervous system inflammation. J. Immunol. 158: 2318.
93. Jensen, M.B., Finsen, B. and Zimmer, J., 1997, Morphological and immunophenotypic microglial changes in denervated fascia dentate of adult rats: correlation with blood-brain barrier damage and astroglial reactions. Exp. Neurol. 143: 103.
94. Jones, T.B., Basso, D.M., Sodhi, A., Pan, J.Z., Hart, R.P., MacCallum, R.C., Lee, S., Whitacre, C.C. and Popovich, P.G., 2002, Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J. Neurosci. 22: 2690.
95. Kerschensteiner, M., Stadelmann, C., Dechant, G., Wekerle, H. and Hohlfeld, R., 2003 Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases. Ann. Neurol. 53: 292.
96. Khimenko, P.L., Moore, T.M., Hill, L.W., Wilson, P.S., Coleman, S., Rizzo, A. and Taylor, A.E., 1995, Adenosine A2 receptors reverse ischemia-reperfusion lung injury independent of beta-receptors. J. Appl. Physiol. 78: 990.
97. Kim, W.G., Mohney, R.P., Wilson, B., Jeohn, G.H., Liu, B. and Hong, J.S., 2000, Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity: role of microglia. J. Neurosci. 20: 6309.
98. + regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc. Natl Acad. Sci. USA 99: 15620.
99. Kloss, C.U., Bohatscheck, M., Kreutzberg, G.W. and Raivich, G., 2001, Effect of lipopolysaccharide on the morphology and integrin immunoreactivity of ramified microglia in mouse brain and in cell culture. Exp. Neurol. 168: 32.
100. Kreutzberg, G.W., 1996, Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19: 312.
101. + channel mRNA expression by stimulation of adenosine A2a-receptors in cultured rat microglia. Glia 25: 120.
102. Ladeby, R., Wirenfeldt, M., Garcia-Ovejero, D., Fenger, C., Dissing-Olesen, L., Dalmau, I. and Finsen, B., 2005, Microglial cell population dynamics in the injured adult central nervous system. Brain Res. Rev. 48: 196.
103. + T cells. J. Immunol. 174: 1073.
104. Lee, K.S., Tetzlaff, W. and Kreutzberg, G.W., 1986, Rapid down regulation of hippocampal adenosine receptors following brief anoxia. Brain Res. 380: 155.
105. Lee, Y.C., Chien, C.L., Sun, C.N., Huang, C.L., Huang, N.K., Chiang, M.C., Lai, H.L., Lin, Y.S., Chou, S.Y., Wang, C.K., Tai, M.H., Liao, W.L., Lin, T.N., Liu, F.C. and Chern, Y., 2003, Characterization of the rat A2A adenosine receptor gene: a 4.8-kb promoter-proximal DNA fragment confers selective expression in the central nervous system. Eur. J. Neurosci. 18: 1786.
106. Lee, H.K., Choi, S.S., Han, K.J., Han, E.J. and Suh, H.W., 2004, Roles of adenosine receptors in the regulation of kainic acid-induced neurotoxic responses in mice. Mol. Brain Res. 125: 76.
107. Leibovich, S.J., Chen, J.F., Pinhal-Enfield, G., Belem, P.C., Elson, G., Rosania, A., Ramanathan, M., Montesinos, C., Jacobson, M., Schwarzschild, M.A., Fink, J.S. and Cronstein, B., 2002, Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A2A receptor agonists and endotoxin. Am. J. Pathol. 160: 2231.
108. Linden, J., 2005, Adenosine in tissue protection and tissue regeneration. Mol. Pharmacol. 67: 1385.
109. Link, A.A., Kino, T., Worth, J.A., McGuire, J.L., Crane, M.L., Chrousos, G.P., Wilder, R.L. and Elenkov, I.J., 2000, Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. J. Immunol. 164: 436.
110. Lipton, S.A. and Rosenberg, P.A., 1994, Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330: 613.
111. Liu, B. and Hong, J.S., 2003, Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 304: 1.
112. Lopes, L.V., Cunha, R.A. and Ribeiro, J.A., 1999, Cross talk between A1 and A2A adenosine receptors in the hippocampus and cortex of young adult and old rats. J. Neurophysiol. 82: 3196.
113. Lopes, L.V., Cunha, R.A., Kull, B., Fredholm, B.B. and Ribeiro, J.A., 2002, Adenosine A2A receptor facilitation of hippocampal synaptic transmission is dependent on tonic A1 receptor inhibition. Neuroscience 112: 319.
114. Lopes, L.V., Halldner, L., Rebola, N., Johansson, B., Ledent, C., Chen, J.F., Fredholm, B.B. and Cunha, R.A., 2004, Binding of the prototypical adenosine A2A receptor agonist CGS 21680 to the cerebral cortex of adenosine A1 and A2A receptor knockout mice. Br. J. Pharmacol. 141: 1006.
115. Lucas, S.M., Rothwell, N.J. and Gibson, R.M., 2006, The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147: S232.
116. Lucchi, R., Latini, S., de Mendonça, A., Sebastião, A.M. and Ribeiro, J.A., 1996, Adenosine by activating A1 receptors prevents GABAA-mediated actions during hypoxia in the rat hippocampus. Brain Res. 732: 261.
117. Lyons, S.A., Pastor, A., Ohlemeyer, C., Kann, O., Wiegand, F., Prass, K., Kettenmann, H. and Dirnagl, U., 2000, Distinct physiologic properties of microglia and blood-borne cells in rat brain slices after permanent middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 20: 1537.
118. Maddock, H.L., Broadley, K.J., Bril, A. and Khandoudi, N., 2001, Role of endothelium in ischaemia-induced myocardial dysfunction of isolated working hearts: cardioprotection by activation of adenosine A2A receptors. J. Auton. Pharmacol. 21: 263.
119. Magnus, T., Chan, A., Linker, R.A., Toyka, K.V. and Gold, R., 2002, Astrocytes are less efficient in the removal of apoptotic lymphocytes than microglia cells: implications for the role of glial cells in the inflamed central nervous system. J. Neuropathol. Exp. Neurol. 61: 760.
120. Marchetti, B. and Abbracchio, M.P., 2005, To be or not to be (inflamed)-is that the question in anti-inflammatory drug therapy of neurodegenerative disorders? Trends Pharmacol. Sci. 26: 517.
121. Marchi, M., Raiteri, L., Risso, F., Vallarino, A., Bonfanti, A., Monopoli, A., Ongini, E. and Raiteri, M., 2002, Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes. Br. J. Pharmacol. 136: 434.
122. Marcoli, M., Raiteri, L., Bonfanti, A., Monopoli, A., Ongini, E., Raiteri, M. and Maura, G., 2003, Sensitivity to selective adenosine A1 and A2A receptor antagonists of the release of glutamate induced by ischemia in rat cerebrocortical slices. Neuropharmacology 45: 201.
123. Marcoli, M., Bonfanti, A., Roccatagliata, P., Chiaramonte, G., Ongini, E., Raiteri, M. and Maura, G., 2004, Glutamate efflux from human cerebrocortical slices during ischemia: vesicular-like mode of glutamate release and sensitivity to A2A adenosine receptor blockade. Neuropharmacology 47: 884.
124. Matsuura, K., Kabuto, H., Makino, H. and Ogawa, N., 1997, Initial cyclosporin A but not glucocorticoid treatment promotes recovery of striatal dopamine concentration in 6-hydroxydopamine lesioned mice. Neurosci. Lett. 230: 191.
125. Matyszak, M.K., 1998, Inflammation in the CNS: balance between immunological privilege and immune responses. Prog. Neurobiol. 56: 19.
126. Mayne, M., Fotheringham, J., Yan, H.J., Power, C., Del Bigio, M.R., Peeling, J. and Geiger, J.D., 2001, Adenosine A2A receptor activation reduces proinflammatory events and decreases cell death following intracerebral hemorrhage. Ann. Neurol. 49: 727.
127. McColl, S.R., St-Onge, M., Dussault, A.A., Laflamme, C., Bouchard, L., Boulanger, J. and Pouliot, M., 2006, Immunomodulatory impact of the A2A adenosine receptor on the profile of chemokines produced by neutrophils. FASEB J. 20: 187.
128. McGeer, P.L. and McGeer, E.G., 2002, Local neuroinflammation and the progression of Alzheimer's disease. J. Neurovirol. 8: 529.
129. McGeer, P.L. and McGeer, E.G., 2004, Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat. Disord. 10: S3.
130. McGeer, P.L. and McGeer, E.G., 2006, NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies. Neurobiol. Aging. 28: 639.
131. McGeer, E.G., Klegeris, A. and McGeer, P.L., 2005, Inflammation, the complement system and the diseases of aging. Neurobiol. Aging 26(Suppl 1): 94.
132. McPherson, J.A., Barringhaus, K.G., Bishop, G.G., Sanders, J.M., Rieger, J.M., Hesselbacher, S.E., Gimple, L.W., Powers, E.R., Macdonald, T., Sullivan, G., Linden, J. and Sarembock, I.J., 2001, Adenosine A2A receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model. Arterioscler. Thromb. Vasc. Biol. 21: 791.
133. Melchior, B., Puntambekar, S.S. and Carson, M.J., 2006, Microglia and the control of autoreactive T cell responses. Neurochem. Int. 49: 145.
134. Minghetti, L., 2005, Role of inflammation in neurodegenerative diseases. Curr. Opin. Neurol. 18: 315.
135. Miwa, T., Furukawa, S., Nakajima, K., Furukawa, Y. and Kohsaka, S., 1997, Lipopolysaccharide enhances synthesis of brain-derived neurotrophic factor in cultured rat microglia. J. Neurosci. Res. 50: 1023.
136. Mizuma, H., Takagi, K., Miyake, K., Takagi, N., Ishida, K., Takeo, S., Nitta, A., Nomoto, H., Furukawa, Y. and Furukawa, S. 1999, Microsphere embolism-induced elevation of nerve growth factor level and appearance of nerve growth factor immunoreactivity in activated T-lymphocytes in the rat brain. J. Neurosci. Res. 55: 749.
137. Moalem, G., Leibowitz-Amit, R., Yoles, E., Mor, F., Cohen, I.R. and Schwartz, M., 1999, Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5: 49.
138. Moalem, G., Gdalyahu, A., Shani, Y., Otten, U., Lazarovici, P., Cohen, I.R. and Schwartz, M., 2000, Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J. Autoimmun. 15: 331.
139. Modlinger, P.S. and Welch, W.J., 2003, Adenosine A1 receptor antagonists and the kidney. Curr. Opin. Nephrol. Hypertens. 12: 497.
140. Monje, M.L., Toda, H. and Palmer, T.D., 2003, Inflammatory blockade restores adult hippocampal neurogenesis. Science 302: 1760.
141. Montesinos, M.C., Desai, A., Chen, J.F., Yee, H., Schwarzschild, M.A., Fink, J.S. and Cronstein, B.N., 2002, Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A2A receptors. Am. J. Pathol. 160: 2009.
142. Morale, M.C., Serra, P.A., L'episcopo, F., Tirolo, C., Caniglia, S., Testa, N., Gennuso, F., Giaquinta, G., Rocchitta, G., Desole, M.S., Miele, E. and Marchetti, B., 2006, Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration. Neuroscience 138: 869.
143. Nash, J.E. and Brotchie, J.M., 2000, A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson's disease. J. Neurosci. 20: 7782.
144. Nataf, S., Anginot, A., Vuaillat, C., Malaval, L., Fodil, N., Chereul, E., Langlois, J.B., Dumontel, C., Cavillon, G., Confavreux, C., Mazzorana, M., Vico, L., Belin, M.F., Vivier, E., Tomasello, E. and Jurdic, P., 2005, Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages. Am. J. Pathol. 166: 275.
145. Neuhaus, O., Farina, C., Wekerle, H. and Hohlfeld, R., 2001, Mechanisms of action of glatiramer acetate in multiple sclerosis. Neurology 56: 702.
146. Neumann, H., Misgeld, T., Matsumuro, K. and Wekerle, H., 1998, Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor. Proc. Natl Acad. Sci. USA 95: 5779.
147. Newby, A.C., 1984, Adenosine and the concept of retaliatory metabolite. Trends Biochem. Sci. 9: 42.
148. Nguyen, M.D., Julien, J.P. and Rivest, S., 2002, Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat. Rev. Neurosci. 3: 216.
149. Niederkorn, J.Y., 2006, See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat. Immunol. 7: 354.
150. Nimmerjahn, A., Kirchhoff, F. and Helmchen, F., 2005, Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308: 1314.
151. Nishizaki, T., Nagai, K., Nomura, T., Tada, H., Kanno, T., Tozaki, H., Li, X.X., Kondoh, T., Kodama, N., Takahashi, E., Sakai, N., Tanaka, K. and Saito, N., 2002, A new neuromodulatory pathway with a glial contribution mediated via A2a adenosine receptors. Glia 39: 133.
152. Odashima, M., Otaka, M., Jin, M., Komatsu, K., Wada, I., Matsuhashi, T., Horikawa, Y., Hatakeyama, N., Oyake, J., Ohba, R., Linden, J. and Watanabe, S., 2005a, Selective adenosine A2A receptor agonist, ATL-146e, attenuates stress-induced gastric lesions in rats. J. Gastroenterol. Hepatol. 20: 275.
153. Odashima, M., Otaka, M., Jin, M., Komatsu, K., Wada, I., Matsuhashi, T., Horikawa, Y., Hatakeyama, N., Oyake, J., Ohba, R., Linden, J. and Watanabe, S., 2005b, Selective A2A adenosine agonist ATL-146e attenuates acute lethal liver injury in mice. J. Gastroenterol. 40: 526.
154. Odashima, M., Bamias, G., Rivera-Nieves, J., Linden, J., Nast, C.C., Moskaluk, C.A., Marini, M., Sugawara, K., Kozaiwa, K., Otaka, M., Watanabe, S. and Cominelli, F., 2005c, Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. Gastroenterology 129: 26.
155. +-related A1/A2 adenosine receptor cooperation. Eur. J. Neurosci. 8: 1124.
156. Ohta, A. and Sitkovsky, M., 2001, Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414: 916.
157. O'Keefe, G.M., Nguyen, V.T. and Benveniste, E.N., 2002, Regulation and function of class II major histocompatibility complex, CD40, and B7 expression in macrophages and microglia: implications in neurological diseases. J. Neurovirol. 8: 496.
158. Okusa, M.D., Linden, J., Huang, L., Rieger, J.M., Macdonald, T.L. and Huynh, L.P., 2000, A2A adenosine receptormediated inhibition of renal injury and neutrophil adhesion. Am. J. Physiol. 279: F809.
159. Olsson, T., Cronberg, T., Rytter, A., Asztely, F., Fredholm, B.B., Smith, M.L. and Wieloch, T., 2004, Deletion of the adenosine A1 receptor gene does not alter neuronal damage following ischaemia in vivo or in vitro. Eur. J. Neurosci. 20: 1197.
160. O'Regan, M., 2005, Adenosine and the regulation of cerebral blood flow. Neurol. Res. 27: 175.
161. Osswald, H., Vallon, V. and Muhlbauer, B., 1996, Role of adenosine in tubuloglomerular feedback and acute renal failure. J. Auton. Pharmacol. 16: 377.
162. Panther, E., Idzko, M., Herouy, Y., Rheinen, H., Gebicke-Haerter, P.J., Mrowietz, U., Dichmann, S. and Norgauer, J., 2001, Expression and function of adenosine receptors in human dendritic cells. FASEB J. 15: 1963.
163. Panther, E., Corinti, S., Idzko, M., Herouy, Y., Napp, M., la Sala, A., Girolomoni, G. and Norgauer, J., 2003, Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. Blood 101: 3985.
164. Pearson, T. and Frenguelli, B.G., 2004, Adrenoceptor subtype-specific acceleration of the hypoxic depression of excitatory synaptic transmission in area CA1 of the rat hippocampus. Eur. J. Neurosci. 20: 1555.
165. Peirce, S.M., Skalak, T.C., Rieger, J.M., Macdonald, T.L. and Linden, J., 2001, Selective A2A adenosine receptor activation reduces skin pressure ulcer formation and inflammation. Am. J. Physiol. 281: H67.
166. Pellerin, L., 2005 How astrocytes feed hungry neurons. Mol. Neurobiol. 32: 59.
167. Perry, V.H., Andersson, P.B. and Gordon, S., 1933, Macrophages and inflammation in the central nervous system. Trends Neurosci. 16: 268.
168. Piehl, F. and Lidman, O., 2001, Neuroinflammation in the rat-CNS cells and their role in the regulation of immune reactions. Immunol. Rev. 184: 212.
169. Pinhal-Enfield, G., Ramanathan, M., Hasko, G., Vogel, S.N., Salzman, A.L., Boons, G.J. and Leibovich, S.J., 2003, An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A2A receptors. Am. J. Pathol. 163: 711.
170. Pinto-Duarte, A., Coelho, J.E., Cunha, R.A., Ribeiro, J.A. and Sebastião, A.M., 2005, Adenosine A2A receptors control the extracellular levels of adenosine through modulation of nucleoside transporters activity in the rat hippocampus. J. Neurochem. 93: 595.
171. Pintor, A., Galluzzo, M., Grieco, R., Pezzola, A., Reggio, R. and Popoli, P., 2004, Adenosine A2A receptor antagonists prevent the increase in striatal glutamate levels induced by glutamate uptake inhibitors. J. Neurochem. 89: 152.
172. Platts, S.H., Linden, J. and Duling, B.R., 2003, Rapid modification of the glycocalyx caused by ischemia-reperfusion is inhibited by adenosine A2A receptor activation. Am. J. Physiol. 284: H2360.
173. Polazzi, E., Gianni, T. and Contestabile, A., 2001, Microglial cells protect cerebellar granule neurons from apoptosis: evidence for reciprocal signaling. Glia 36: 271.
174. Popoli, P., Frank, C., Tebano, M.T., Potenza, R.L., Pintor, A., Domenici, M.R., Nazzicone, V., Pezzola, A. and Reggio, R., 2003, Modulation of glutamate release and excitotoxicity by adenosine A2A receptors. Neurology 61: S69.
175. Ponzio, T.A., Wang, Y.F. and Hatton, G.I., 2006, Activation of adenosine A2A receptors alters postsynaptic currents and depolarizes neurons of the supraoptic nucleus. Am. J. Physiol. 291: 359.
176. Raivich, G., 2005, Like cops on the beat: the active role of resting microglia. Trends Neurosci. 28: 571.
177. Raivich, G., Bohatschek, M., Kloss, C.U., Werner, A., Jones, L.L. and Kreutzberg, G.W., 1999, Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res. Rev. 30: 77.
178. + regulatory T cells and their therapeutic potential. Annu. Rev. Med. 57: 381.
179. Ransohoff, R.M. and Tani, M., 1998, Do chemokines mediate leukocyte recruitment in post-traumatic CNS inflammation? Trends Neurosci. 21: 154.
180. Rebola, N., Pinheiro, P.C., Oliveira, C.R., Malva, J.O. and Cunha, R.A., 2003, Subcellular localization of adenosine A1 receptors in nerve terminals and synapses of the rat hippocampus. Brain Res. 987: 49.
181. Rebola, N., Canas, P.M., Oliveira, C.R. and Cunha, R.A., 2005a, Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat. Neuroscience 132: 893.
182. Rebola, N., Rodrigues, R.J., Lopes, L.V., Richardson, P.J., Oliveira, C.R. and Cunha, R.A., 2005b, Adenosine A1 and A2A receptors are co-expressed in pyramidal neurons and co-localized in glutamatergic nerve terminals of the rat hippocampus. Neuroscience 133: 79.
183. Rebola, N., Porciúncula, L.O., Lopes, L.V., Oliveira, C.R., Soares-da-Silva, P. and Cunha, R.A., 2005c, Long-term effect of convulsive behavior on the density of adenosine A1 and A2A receptors in the rat cerebral cortex. Epilepsia 46(Suppl 5): 159.
184. Ritchie, P.K., Spangelo, B.L., Krzymowski, D.K., Rossiter, T.B., Kurth, E. and Judd, A.M., 1997, Adenosine increases interleukin 6 release and decreases tumour necrosis factor release from rat adrenal zona glomerulosa cells, ovarian cells, anterior pituitary cells, and peritoneal macrophages. Cytokine 9: 187.
185. Rodrigues, R.J., Alfaro, T.M., Rebola, N., Oliveira, C.R. and Cunha, R.A., 2005, Co-localization and functional interaction between adenosine A2A and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum. J. Neurochem. 92: 433.
186. Ross, S.D., Tribble, C.G., Linden, J., Gangemi, J.J., Lanpher, B.C., Wang, A.Y. and Kron, I.L., 1999, Selective adenosine-A2A activation reduces lung reperfusion injury following transplantation. J. Heart Lung Transplant. 18: 994.
187. Rossi, D.J., Oshima, T. and Attwell, D., 2000, Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403: 316.
188. Sargsyan, S.A., Monk, P.N. and Shaw, P.J., 2005, Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia 51: 241.
189. Saura, J., Angulo, E., Ejarque, A., Casadó, V., Tusell, J.M., Moratalla, R., Chen, J.F., Schwarzschild, M.A., Lluis, C., Franco, R. and Serratosa, J., 2005, Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia. J. Neurochem. 95: 919.
190. Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Liao, Z., Lieberburg, I., Motter, R., Mutter, L., Soriano, F., Shopp, G., Vasquez, N., Vandevert, C., Walker, S., Wogulis, M., Yednock, T., Games, D. and Seubert, P., 1999, Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400: 173.
191. Schnurr, M., Toy, T., Shin, A., Hartmann, G., Rothenfusser, S., Soellner, J., Davis, I.D., Cebon, J. and Maraskovsky, E., 2004, Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells. Blood 103: 1391.
192. + regulatory T cells. Ann. N.Y. Acad. Sci. 1051: 701.
193. Schwartz, M. and Moalem, G., 2001, Beneficial immune activity after CNS injury: prospects for vaccination. J. Neuroimmunol. 113: 185.
194. Schwartz, M., Moalem, G., Leibowitz-Amit, R. and Cohen, I.R., 1999, Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci. 22: 295.
195. Schwartz, M., Shaked, I., Fisher, J., Mizrahi, T. and Schori, H., 2003, Protective autoimmunity against the enemy within: fighting glutamate toxicity. Trends Neurosci. 26: 297.
196. Schwartz, M., Butovsky, O., Bruck, W. and Hanisch, U.K., 2006, Microglial phenotype: is the commitment reversible? Trends Neurosci. 29: 68.
197. Shryock, J.C. and Belardinelli, L., 1997, Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am. J. Cardiol. 79: 2.
198. Sitkovsky, M.V., 2003, Use of the A2A adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo. Biochem. Pharmacol. 65: 493.
199. Sitkovsky, M.V. and Ohta, A., 2005, The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol. 26: 299.
200. Sitkovsky, M.V., Lukashev, D., Apasov, S., Kojima, H., Koshiba, M., Caldwell, C., Ohta, A. and Thiel, M., 2004, Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu. Rev. Immunol. 22: 657.
201. Sriram, K., Matheson, J.M., Benkovic, S.A., Miller, D.B., Luster, M.I. and O'Callaghan, J.P., 2006a, Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-?. FASEB J. 20: 670.
202. Sriram, K., Miller, D.B. and O'Callaghan, J.P., 2006b, Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-?. J. Neurochem. 96: 706.
203. Stone, T.W., 1985, Purines: Pharmacology and Physiological Roles. MacMillan, London.
204. Streit, W.J., Walter, S.A. and Pennell, N.A., 1999, Reactive microgliosis. Prog. Neurobiol. 57: 563.
205. Sullivan, G.W., Linden, J., Buster, B.L. and Scheld, W.M., 1999, Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram. J. Infect. Dis. 180: 1550.
206. Svenningsson, P., Le Moine, C., Fisone, G. and Fredholm, B.B., 1999, Distribution, biochemistry and function of striatal adenosine A2A receptors. Prog. Neurobiol. 59: 355.
207. Takahashi, K., Rochford, C.D. and Neumann, H., 2005, Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 201: 647.
208. Tebano, M.T., Martire, A., Rebola, N., Pepponi, R., Domenici, M.R., Gro, M.C., Schwarzschild, M.A., Chen, J.F., Cunha, R.A. and Popoli, P., 2005, Adenosine A2A receptors and metabotropic glutamate 5 receptors are colocalized and functionally interact in the hippocampus: a possible key mechanism in the modulation of Nmethyl- D-aspartate effects. J. Neurochem. 95: 1188.
209. Teismann, P. and Schulz, J.B., 2004, Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation. Cell Tissue Res. 318: 149.
210. Tetzlaff, W., Schubert, P. and Kreutzberg, G.W., 1987, Synaptic and extrasynaptic localization of adenosine binding sites in the rat hippocampus. Neuroscience 21: 869.
211. Togo, T., Akiyama, H., Iseki, E., Kondo, H., Ikeda, K., Kato, M., Oda, T., Tsuchiya, K. and Kosaka, K., 2002, Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases. J. Neuroimmunol. 124: 83.
212. van Calker, D. and Biber, K., 2005, The role of glial adenosine receptors in neural resilience and the neurobiology of mood disorders. Neurochem. Res. 30: 1205.
213. van Gool, W.A., Aisen, P.S. and Eikelenboom, P., 2003, Anti-inflammatory therapy in Alzheimer's disease: is hope still alive? J. Neurol. 250: 788.
214. Vezzani, A. and Granata, T., 2005, Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46: 1724.
215. Villoslada, P., Hauser, S.L., Bartke, I., Unger, J., Heald, N., Rosenberg, D., Cheung, S.W., Mobley, W.C., Fisher, S. and Genain, C.P., 2000, Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J. Exp. Med. 191: 1799.
216. +-induced dopaminergic neurodegeneration: role of 67 kDa laminin receptor. FASEB J. 20: 906.
217. Wei, R. and Jonakait, G.M., 1999, Neurotrophins and the anti-inflammatory agents interleukin-4 (IL-4), IL-10, IL-11 and transforming growth factor-?1 (TGF-?1) down-regulate T cell costimulatory molecules B7 and CD40 on cultured rat microglia. J. Neuroimmunol. 95: 8.
218. Weiner, H.L. and Selkoe, D.J., 2002, Inflammation and therapeutic vaccination in CNS diseases. Nature 420: 879.
219. Wirkner, K., Assmann, H., Koles, L., Gerevich, Z., Franke, H., Norenberg, W., Boehm, R. and Illes, P., 2000, Inhibition by adenosine A2A receptors of NMDA but not AMPA currents in rat neostriatal neurons. Br. J. Pharmacol. 130: 259.
220. Wirkner, K., Gerevich, Z., Krause, T., Gunther, A., Koles, L., Schneider, D., Norenberg, W. and Illes, P., 2004, Adenosine A2A receptor-induced inhibition of NMDA and GABAA receptor-mediated synaptic currents in a subpopulation of rat striatal neurons. Neuropharmacology 46: 994.
221. Wu, D.C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.K., Ischiropoulos, H. and Przedborski, S., 2002, Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 22: 1763.
222. Xu, K., Bastia, E. and Schwarzschild, M., 2005, Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease. Pharmacol. Ther. 105: 267.
223. Yoles, E., Hauben, E., Palgi, O., Agranov, E., Gothilf, A., Cohen, A., Kuchroo, V., Cohen, I.R., Weiner, H. and Schwartz, M., 2001, Protective autoimmunity is a physiological response to CNS trauma. J. Neurosci. 21: 3740.
224. Yu, L., Huang, Z., Mariani, J., Wang, Y., Moskowitz, M. and Chen, J.F., 2004, Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury. Nat. Med. 10: 1081.
225. Zandi, P.P., Anthony, J.C., Hayden, K.M., Mehta, K., Mayer, L., Breitner, J.C., Cache County Study Investigators, 2002, Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study. Neurology 59: 880